FACULTY
​

PROF KALEVI KAIREMO
​
President
World Association of Radiopharmaceutical and Molecular Therapy WARMTH
Finland

Prof Kairemo graduated with a MSc (Eng) degree from Helsinki University of Technology (Chemical Engineering) in 1980 before undertaking medical training (MD (86), PhD (93)) at the University of Helsinki, Finland. He undertook specialist training in Clinical Chemistry (94), Nuclear Medicine (96), Health Care Administration (02) and Pharmaceutical Medicine (06) at Helsinki University Central Hospital. He had a post-doctoral research fellowship at Memorial Sloan-Kettering Cancer Center in 1989-93 in New York. Besides homeland Finland he is licensed medical specialist in Norway (1998), Sweden (2001) and Estonia (2010).

Prof Kairemo has held posts as Professor in Clinical Chemistry at the Norwegian University of Science and Technology (1998-9), Professor in Nuclear Medicine at Uppsala University Hospital in Sweden (2001-5) and as Head of the Nuclear Medicine Division, Department of Oncology at Helsinki University Central Hospital (2004-9). In 2009-2018, he has been the Chief of Nuclear Medicine and Molecular Radiotherapy (Theragnostics) at the Docrates Cancer Center, in Helsinki. Since 2015 he has acted as Visiting Professor in the Nuclear Medicine Department of The University of Texas MD Anderson Cancer Center, in Houston, TX; last visits in 2019, 2022 and 2023.

Prof Kairemo has also held posts in industry, as Medical Director of CTT Cancer Targeting Technologies Oy (2001-6), Medical Director of Imanext Oy (2006-8) and Clinical Director at Advanced Accelerator Applications SA in 2009 (now Novartis Co.).
​
Besides a few patents prof Kairemo has published more than 250 original publications in peer-reviewed journals . He received the Lifetime Achievement Award from the World Association of Radiopharmaceutical and Molecular Therapy in 2012 and was President of the 7th International Conference on Radiopharmaceutical Therapy held in November 2012 in Levi in Finnish Lapland. In 2014, Dr Kairemo hosted ISORBE Symposium and Workshop “Cell Labelling and Cell Therapies” in Helsinki. He organized also the International Symposium on Radiopharmaceutical Therapy (WARMTH) in November 2018 in Helsinki. He is currently the President of the World Association of Radiopharmaceutical and Molecular Therapy WARMTH.